Informasjon
NSAIDs
NSAIDs utgjør en stor gruppe legemidler med relativt lik betennelsesdempende virkning. Ulempen er at midlene kan forårsake mageplager, i noen tilfeller mageblødninger.
Sist oppdatert:
25. okt. 2021
Dette dokumentet er basert på det profesjonelle dokumentet M01A NSAIDs . Referanselisten for dette dokumentet vises nedenfor
Referanser
- Reikvam Å, Hexeberg S, Kvien TK, et al. Klinisk bruk av COX-hemmere - en konsensus. Tidsskr Nor Lægeforen 2006; 126: 591-5. PubMed
- Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono C. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ 2006; 332: 1302-8. British Medical Journal
- McGettigan P, Henry D. Cardiovascular risk and inhibition of cyclooxygenase. A systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. JAMA 2006; 296: 1633-44. Journal of the American Medical Association
- Schmidt M, Sørensen HT, Pedersen L. Diclofenac use and cardiovascular risks: series of nationwide cohort studies. BMJ 2018; 362: k3426. doi:10.1136/bmj.k3426 DOI
- Bally M, Dendukuri N, Rich B, et al. Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data.. BMJ 2017. pmid:28487435 PubMed
- Schjerning Olsen A, Fosbøl L, Lindhardsen J, et al. Long-term cardiovascular risk of NSAID use according to time passed after first-time myocardial infarction. A nationwide cohort study. Circulation 2012. doi:10.1161/CIRCULATIONAHA.112.112607.
- Laine L, White WB, Rostom A, Hochberg M. COX-2 Selective inhibitors in the treatment of osteoarthritis. Semin Arthritis Rheum 2008; Epub ahead of print.
- Nissen SE, Yeomans ND, Solomon DH, et al. Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis. N Engl J Med 2016 Dec; 375(26): 2519-29. pmid:27959716 PubMed
- Graham DJ, Campen D, Hui R, et al. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study. Lancet 2005; 365: 475-81. PubMed
- Vaile JH, Davis P. Topical NSAIDs for musculoskeletal conditions. A review of the literature. Drugs 1998; 56: 783-99. PubMed
- Moore RA, Tramer MR, Carroll D, Wiffen PJ, McQuay HJ. Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs. BMJ 1998; 316: 333-8. PubMed
- Lin J, Zhang W, Jones A, Doherty M. Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials. BMJ 2004; 329: 324-6. PubMed
- Derry S, Conaghan P, Da Silva JA. Topical NSAIDs for chronic musculoskeletal pain in adults. Cochrane Database Syst Rev 2016 Apr; 4: CD007400. pmid:27103611 PubMed
- Deng ZH, Zeng C, Yang Y, et al. Topical diclofenac therapy for osteoarthritis: a meta-analysis of randomized controlled trials. Clin Rheumatol 2016 May; 35(5): 1253-61. pmid:26242469 PubMed
- Gøtzsche P. Non-steroidal anti-inflammatory drugs. Clin Evid 2001; 6: 894-901. Clinical Evidence
- Gøtzsche P. Meta-analysis of NSAIDs: contribution of drugs, doses, trial designs, and meta-analytic techniques. Scand J Rheumatol 1993; 22: 255-60. PubMed
- Simon LS, Weaver AL, Graham DY, et al. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis. JAMA 1999; 282: 1921-8. Journal of the American Medical Association
- Hooper L, Brown TJ, Elliott R, Payne K, Roberts C, Symmons D. The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review. BMJ 2004; 329: 948. British Medical Journal
- Scarpignato C, Gatta L, Zullo A, et al. Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression. BMC Med 2016 Nov; 14(1): 179. pmid:27825371 PubMed
- RELIS: Diklofenak til korttidsbruk og kardiovaskulær sykdom relis.no
- Legeforeningen. Gjør kloke valg. Norsk forening for allmennmedisin. Unngå å forskrive NSAID uten at det foreligger spesifikk grunn og risiko for bivirkninger er vurdert. Publisert 04.07.2018. Siden besøkt 29.12.2023 www.legeforeningen.no
- Risser A, Donovan D, Heintzman J, Page T. NSAID prescribing precautions. Am Fam Physician 2009; 80: 1371-8. American Family Physician
- Rugstad HE, Giercksky K-E, Husby G, Holme I. Effect of cimetidine on gastrointestinal symptoms in patients taking nonsteroidal anti-inflammatory drugs. Scand J Rheumatol 1994; 23: 177-82. PubMed
- Emery P, Zeidler H, Kvien TK, Guslandi M, Naudin R, Sted H et al. Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison. Lancet 1999; 354: 2106-11. PubMed
- Rostom A, Dube C, Wells G, Tugwell P, Welch V, Jolicoeur E, McGowan J. Prevention of NSAID-induced gastroduodenal ulcers (Cochrane Review). In: The Cochrane Library, Issue 4, 2002. The Cochrane Library
- Slørdal L, Spigset O. Hypertensjon og hjertesvikt forårsaket av NSAID-preparater. Tidsskr Nor Lægeforen 2000; 120: 2904-5. Tidsskrift for Den norske legeforening
- Skomsvoll JF, Rødevand E, Koksvik HS, et al. Reversibel infertilitet ved ikke-steroide antiinflammatoriske midler. Tidsskr Nor Lægeforen 2005; 125: 1476-8. PubMed
- Os I. COX-2-hemmere og effekt på nyrer og blodtrykk. Tidsskr Nor Lægeforen 2003; 123: 1339-41. PubMed
- Nielsen GL, Sørensen HT, Larsen H, Pedersen L. Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study. BMJ 2001; 322: 266-70. PubMed
- Nakhai-Pour HR, Broy P, Sheehy O, Bérard A. Use of nonaspirin non-steroidal antiinflammatory drugs during pregnancy and the risk of spontaneous abortion . CMAJ 2011; 183: 1713-20. Canadian Medical Association Journal
- Daniel S, Koren G, Lunenfeld E, et al. Fetal exposure to nonsteroidal anti-inflammatory drugs and spontaneous abortions. CMAJ. 2014;186:E177-82. PMID: 24491470 PubMed
- Daniel S, Matok I, Gorodischer R, et al. Major malformations following exposure to nonsteroidal antiinflammatory drugs during the first trimester of pregnancy. J Rheumatol 2012; 39: 2163-9. PubMed
- Statens legemiddelverk. Nytt om legemidler no 5; 2014.
- Cerezo JG, Hristov RL, Carcas Sansuán AJ, Vázquez Rodríguez JJ. Outcome trials of COX-2 selective inhibitors: global safety evaluation does not promise benefits. Eur J Clin Pharm 2003; 59: 169-175. PubMed
- Evensen S, Spigset O, Slørdal L. COX-2-hemmere - ett skritt frem og to tilbake. Tidsskr Nor Lægeforen 2005; 125: 875-8. PubMed
- Updated advice on use of high-dose ibuprofen. European Medicines Agency. Press releaase 22.05.2015
- Coxib and traditional NSAIDs Trialists Collaboration. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analysis of individual participant data from randomised trials. Lancet 2013; May 29 doi:pii: S0140-6736(13)60900-9. 10.1016/S0140-6736(13)60900-9.Epub ahead of print
- Borregaard Larsen J, Thirstrup Pedersen S. Nonsteroide antiinflammatoriske stoffer - mulige risici ved anvendelse under graviditet. Ugeskr Læger 2006; 168: 3709-11. PubMed
- Coxib and traditional NSAID Trialists’ (CNT) Collaboration. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet 2013; 382: 769-779. PubMed
- Helin-Salmivaara A, Virtanen A, Vesalainen R, et al. NSAID use and the risk of hospitalization for first myocardial infarction in the general population: a nationwide case-control study from Finland. Eur Heart J 2006; 27: 1657-63. European Heart Journal